Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
03/2009
03/31/2009CA2356121C Novel propargylether derivatives
03/26/2009WO2009037111A2 Method for the production of 1,3-dioxolane-2-ones and carboxylic acid esters by means of transacylation in basic reaction conditions
03/26/2009US20090082582 Process For Preparing [2-(2,3- Dihydrobenzofuran - Or Benzofuran-7-Yloxy)Ethyl]-(3 -Cyclopent-1-Ylbenzyl)Amine Derivatives and Synthesis Intermediate
03/26/2009US20090082431 Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
03/26/2009US20090082395 Soluble epoxide hydrolase inhibitors
03/26/2009US20090082328 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
03/26/2009US20090082311 2-Aminobutanol Compound and Use Thereof for Medical Purposes
03/26/2009CA2699909A1 Process for preparing 1,3-dioxolan-2-ones as well as carboxylic acid esters by transacylation under basic reaction conditions
03/25/2009EP2038249A1 Process for preparing gabapentin
03/25/2009CN101395147A 1-(benzo (d) (1,3) dioxol-5-yl) -n- (phenyl) cyclopropane- carboxamide derivatives and related compounds as modulators of atp-binding cassette transporters for the treatment of cystic fibrosis
03/25/2009CN101395146A Process for preparing [2-(2,3-dihydrobenzofuran- or benzofuran-7-yloxy)ethyl]-(3-cyclopent-1-ylbenzyl)amine derivatives and synthesis intermediate
03/25/2009CN101390852A Melanogenesis inhibitor and skin preparation containing the same
03/24/2009US7507860 Androgen modulators
03/24/2009US7507838 Treating tartaric acid bis(acetonide) such as 2,2,2',2'-tetramethyl-[4,4']bis[[1,3]dioxolanyl]-5,5'-dione with potassium tert-butoxide in to form the Z-5-carboxymethylene-1,3-dioxolan-4-one; as chemical intermediate for preparing HIV integrase inhibitors
03/19/2009WO2009035951A2 Soluble epoxide hydrolase inhibitors
03/19/2009WO2009035652A1 Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
03/19/2009WO2009035407A1 Use of intermediates ((r ) -2,2, 4-trimethyl-l, 3-dioxolane-4-yl) methanol (a), 3-f luoro-4-nitro-phenol (b) and 1- (4-chloro- benzyl) -piperidin-4-ylamine (c)
03/19/2009WO2009035269A2 Method of manufacturing glycerol carbonate
03/19/2009US20090076062 Organic Compounds
03/19/2009CA2698808A1 Synthesis of deuterated catechols and benzo[d][1,3] dioxoles and derivatives thereof
03/19/2009CA2697752A1 Guanidine-containing compounds useful as muscarinic receptor antagonists
03/18/2009EP2036898A2 Method for manufacturing 1.3 dioxolane 2ones and carboxylic acid esters by transacylation under alkaline reaction conditions
03/18/2009CN101389600A Optical isomers of dihydro-2,3-benzodiazepine derivatives, process for their stereoselective synthesis
03/17/2009US7504527 Low corrosive integrated process for preparing dialkyl carbonates
03/17/2009US7504512 BCL-X1 protein inhibitors; anticarcinogenic agents
03/17/2009US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
03/17/2009US7504425 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/17/2009US7504393 Benzylamine analogues
03/17/2009CA2328234C Compounds that inhibit the binding of integrins to their receptors
03/12/2009WO2008145941A3 Coproduction of cyclic carbonates and of nitriles and/or of fatty amines
03/11/2009EP2032535A1 Spirocyclic nitriles as protease inhibitors
03/11/2009EP1940782B1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors
03/11/2009EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/11/2009CN101381339A Prodrugs of gaba analogs, compositions and uses thereof
03/11/2009CN100467436C Process for preparing alkoxy- and aryloxy-phenols
03/10/2009US7501531 Reacting ethylene oxide with CO2 in presence of a catalyst containing zinc chloride or iodide immobililzed in an ion exchange resin ( styrene-divinybenzene copolymer or polyacrylate) solid support with quaternary ammonium, phosphonium, sulfonium, stibonium, arsenomium salts to form ethylene carbonate
03/10/2009US7501417 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
03/05/2009WO2009026961A1 Processes for the preparation of pancratistatin and pancratistatin analogues
03/05/2009WO2009026658A1 Ppar agonists
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
03/05/2009US20090062284 Thio-Substituted Biarylmethanesulfinyl Derivatives
03/05/2009US20090061143 Organic compound for recording layer for high speed recording of information and optical recording medium including the same
03/04/2009EP1720851B1 Process for synthesising heliotropine and its derivatives
03/04/2009EP1485370B1 Amino-derivatives as novel inhibitors of histone deacetylase
03/04/2009EP1472209B1 Lipoxin a4 analogs
03/04/2009CN101379052A Process for the production of alkylene carbonate and use of alkylene carbonate thus produced in the manufacture of an alkane diol and a dialkyl carbonate
03/04/2009CN100466366C Non-aqueous electrolyte and secondary cell of non-aqueous electrolyte
03/03/2009US7498460 Isophthalic acid derivatives
03/03/2009US7498451 Reacting an aliphatic dialdehyde wtih an aliphatic mono- or dialcohol while removing water by distillation; continuously distilling reaction mixture in a dividing wall column to obtain pure monoacetal as a sidestream or by distillation in 2 successive columns to obtain pure monoacetal from the 2nd column
03/03/2009US7498436 Substituted hydroxyethylamines
03/03/2009US7498394 (2-Methyl)-acrylic acid 2-benzyloxycarbonyloxy-ethyl ester; higherpolymerization rates and that polymerize more completely than conventional monomers with multiple vinyl functionalities; curing efficiency, allows optimum polymer properties to be achieved with minimized irradiation times and intensities
02/2009
02/26/2009WO2009026348A2 Antifungal agents from a streptomycete
02/26/2009WO2009024550A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
02/26/2009WO2009024492A1 Leukotriene b4 inhibitors
02/26/2009US20090054607 Transition metal complex, catalyst for olefin polymerization, and process for producing olefin polymer with the same
02/26/2009US20090054422 New Oxabispidine Compounds For The Treatment Of Cardiac Arrhythmias
02/26/2009CA2696967A1 Leukotriene b4 inhibitors
02/26/2009CA2694604A1 N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
02/25/2009EP2027105A2 Novel process for preparing intermediates of ccr antagonists
02/25/2009EP2027087A2 Intracellular kinase inhibitors
02/25/2009EP1143965B1 Carbocyclic potassium channel inhibitors
02/19/2009WO2009005110A3 Halogen-containing organosulfur compound and use thereof
02/19/2009US20090048424 Fluorosulfonyl group-containing monomer and its polymer, and sulfonic acid group-containing polymer
02/19/2009US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
02/19/2009US20090048224 Compounds and methods of use
02/18/2009EP1819238B1 Use of diacetyl trimer as an aromatic and flavouring substance
02/18/2009CN101367788A Preparation method of vinylene carbonate for lithium cell
02/17/2009US7491837 Alkylene oxide is reacted with carbon dioxide in the presence of a halogen-free carbonation catalyst, the cyclic carbonate is then reacted with an alcohol in a carbonation and/or tranesterification catalyst for a dialkyl carbonate and diol
02/17/2009US7491723 Alkanol and cycloalkanol-amine derivatives and methods of their use
02/12/2009CA2830727A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
02/12/2009CA2666246A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
02/10/2009US7488835 Process for the preparation of alkylene carbonates
02/10/2009US7488751 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
02/10/2009CA2336691C Ligands for metals and metal-catalyzed processes
02/05/2009WO2009016087A1 Monoamide derivatives as orexin receptor antagonists
02/05/2009US20090036673 Ecteinascidin 743; 5-(1,2-diaminoethyl-), 3,4-methylenedioxyphenol intermediate, of which the amine group cyclizes
02/05/2009US20090036342 Use of a mixture of esters of fatty acids as fuel or solvent
02/05/2009US20090035358 Phosphatidyl oligoglycerols
02/05/2009CA2694276A1 Monoamide derivatives as orexin receptor antagonists
02/03/2009US7485660 For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease
02/03/2009CA2259936C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
01/2009
01/29/2009WO2008145941A9 Coproduction of cyclic carbonates and of nitriles and/or of fatty amines
01/29/2009WO2008116339A3 Organic compounds
01/28/2009EP2019090A1 Substituted beta-phenyl-alpha-hydroxy propanoic acid, synthesis method and use thereof
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7482313 Bicyclo(3.3.1)nonanes and bicyclo(3.3.1)nonenes and their use as flavor or fragrance ingredient
01/22/2009WO2009011225A1 Process for producing 4-fluoro-1,3-dioxolan-2-one
01/22/2009WO2009010554A1 Process for the enantioselective preparation of pregabalin
01/22/2009WO2009010527A1 Process for preparing cyclic glycerol acetals or cyclic glycerol ketals or mixtures thereof
01/22/2009WO2009010260A2 Condensed anthranilamide insecticides
01/22/2009WO2008142097A3 Method for producing carbonate-terminated compounds
01/22/2009US20090023936 Method of purifying vinylene carbonate
01/22/2009US20090023734 Treating cell proliferative disorders
01/22/2009US20090023718 Diamine and Iminodiacetic Acid Hydroxamic Acid Derivatives
01/22/2009US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections
01/22/2009US20090023093 Acid-amplifier having acetal group and photoresist composition including the same
01/22/2009CA2693843A1 Process for the enantioselective preparation of pregabalin
01/21/2009EP2017274A1 Acid-amplifier having acetal group and photoresist composition including the same
01/21/2009EP2017273A1 Process for the enantioselective preparation of pregabalin
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 183